Galapagos Genomics said last week that it has appointed Staf Van Reet as vice president of corporate development.
Van Reet will be responsible for in-licensing clinical and preclinical compounds, and building a clinical development team at Galapagos, the company said.
Van Reet has held numerous positions at Johnson & Johnson, most recently vice president of Johnson & Johnson Development, the venturing unit of the drug maker, Galapagos said. Prior to that he worked for Janssen Pharmaceutica, a J&J affiliate, where he held such positions as president of the Janssen Research Foundation and managing director.
Van Reet holds a degree in applied biological sciences and a PhD in agricultural sciences from the University of Leuven. He is also a Belgian and European patent attorney, said Galapagos.
Sydney Brenner has received the 2005 UCSD/Merck Life Sciences Achievement Award, the University of California San Diego said last week.
Brenner is a distinguished professor at the Salk Institute for Biological Studies and a recipient of the 2002 Nobel Prize in medicine, as well as an adjunct professor of biology at UCSD. He received the $25,000 award at a dinner at UCSD on April 1.
Brenner was awarded the Nobel Prize for discoveries about how genes regulate organ growth and the process of programmed cell death. He also proved C. elegans to be a useful model organism. In addition, he established the existence of messenger RNA and characterized it further.
Brenner holds a PhD in chemistry from Oxford University and medicine and science degrees from the University of Witwatersand in Johannesburg, South Africa.